Compile Data Set for Download or QSAR
Report error Found 50 Enz. Inhib. hit(s) with all data for entry = 12694
TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602904(CHEMBL5204869 | US20250051335, Compound 2)
Affinity DataIC50: 240nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602922(CHEMBL5184336 | US20250051335, Compound 21)
Affinity DataIC50: 370nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602903(CHEMBL5198544 | US20250051335, Compound 1)
Affinity DataIC50: 390nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602910(CHEMBL5209196 | US20250051335, Compound 8)
Affinity DataIC50: 420nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602906(CHEMBL5187459 | US20250051335, Compound 4)
Affinity DataIC50: 440nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602920(CHEMBL5187125 | US20250051335, Compound 20)
Affinity DataIC50: 450nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602917(CHEMBL5200069 | US20250051335, Compound 14)
Affinity DataIC50: 490nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602911(CHEMBL5171328 | US20250051335, Compound 9)
Affinity DataIC50: 520nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602917(CHEMBL5200069 | US20250051335, Compound 14)
Affinity DataIC50: 530nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602907(CHEMBL5193488 | US20250051335, Compound 5)
Affinity DataIC50: 540nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602921(CHEMBL5180098 | US20250051335, Compound 18)
Affinity DataIC50: 580nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602925(CHEMBL5188513 | US20250051335, Compound 23)
Affinity DataIC50: 650nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602909(CHEMBL5197789 | US20250051335, Compound 7)
Affinity DataIC50: 750nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602926(CHEMBL5200160 | US11814388, Compound 9 | US2025005...)
Affinity DataIC50: 750nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602905(CHEMBL5208565 | US20250051335, Compound 3)
Affinity DataIC50: 770nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602916(CHEMBL5196033 | US20250051335, Compound 17)
Affinity DataIC50: 840nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602903(CHEMBL5198544 | US20250051335, Compound 1)
Affinity DataIC50: 850nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602907(CHEMBL5193488 | US20250051335, Compound 5)
Affinity DataIC50: 970nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602912(CHEMBL5179559 | US20250051335, Compound 10)
Affinity DataIC50: 1.02E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602926(CHEMBL5200160 | US11814388, Compound 9 | US2025005...)
Affinity DataIC50: 1.21E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602909(CHEMBL5197789 | US20250051335, Compound 7)
Affinity DataIC50: 1.21E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602910(CHEMBL5209196 | US20250051335, Compound 8)
Affinity DataIC50: 1.24E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602923(CHEMBL5178871 | US20250051335, Compound 19)
Affinity DataIC50: 1.32E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602928(CHEMBL5209161 | US20250051335, Compound 26)
Affinity DataIC50: 1.50E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602914(CHEMBL5192144 | US20250051335, Compound 12)
Affinity DataIC50: 1.55E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602927(CHEMBL5193908 | US20250051335, Compound 25)
Affinity DataIC50: 1.71E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602906(CHEMBL5187459 | US20250051335, Compound 4)
Affinity DataIC50: 2.14E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602913(CHEMBL5207918 | US20250051335, Compound 11)
Affinity DataIC50: 2.20E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM720563(US20250051335, Compound 16)
Affinity DataIC50: 2.30E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602920(CHEMBL5187125 | US20250051335, Compound 20)
Affinity DataIC50: 2.70E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602924(CHEMBL5203204 | US20250051335, Compound 22)
Affinity DataIC50: 2.72E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602905(CHEMBL5208565 | US20250051335, Compound 3)
Affinity DataIC50: 3.02E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602922(CHEMBL5184336 | US20250051335, Compound 21)
Affinity DataIC50: 3.05E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602918(CHEMBL5193008 | US20250051335, Compound 15)
Affinity DataIC50: 3.56E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602923(CHEMBL5178871 | US20250051335, Compound 19)
Affinity DataIC50: 3.90E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602904(CHEMBL5204869 | US20250051335, Compound 2)
Affinity DataIC50: 4.22E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602921(CHEMBL5180098 | US20250051335, Compound 18)
Affinity DataIC50: 4.49E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602911(CHEMBL5171328 | US20250051335, Compound 9)
Affinity DataIC50: 4.90E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602925(CHEMBL5188513 | US20250051335, Compound 23)
Affinity DataIC50: 4.94E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602908(CHEMBL5177584 | US20250051335, Compound 6)
Affinity DataIC50: 5.03E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602928(CHEMBL5209161 | US20250051335, Compound 26)
Affinity DataIC50: 5.40E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 1(Human)
Csic

US Patent
LigandPNGBDBM50602915(CHEMBL5182026 | US20250051335, Compound 13)
Affinity DataIC50: 5.61E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM720563(US20250051335, Compound 16)
Affinity DataIC50: 5.72E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602913(CHEMBL5207918 | US20250051335, Compound 11)
Affinity DataIC50: 6.40E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602916(CHEMBL5196033 | US20250051335, Compound 17)
Affinity DataIC50: 6.79E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602912(CHEMBL5179559 | US20250051335, Compound 10)
Affinity DataIC50: 8.79E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602918(CHEMBL5193008 | US20250051335, Compound 15)
Affinity DataIC50: 9.54E+3nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602927(CHEMBL5193908 | US20250051335, Compound 25)
Affinity DataIC50: 1.19E+4nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602924(CHEMBL5203204 | US20250051335, Compound 22)
Affinity DataIC50: 2.27E+4nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetTau-tubulin kinase 2 [1-450](Human)
Csic

US Patent
LigandPNGBDBM50602914(CHEMBL5192144 | US20250051335, Compound 12)
Affinity DataIC50: 1.00E+5nMAssay Description:A buffer solution containing the recombinant human enzyme TTBK1 (1-1321) or TTBK2(1-450) (5-20 mU) and 50 mM Tris at pH 7.5, 0.1 mM EGTA, 0.1% p-merc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent